NasdaqCM - Nasdaq Real Time Price USD
ENDRA Life Sciences Inc. (NDRA)
3.2600
-2.8900
(-46.99%)
At close: May 9 at 4:00:01 PM EDT
3.4789
+0.22
+(6.71%)
Pre-Market: 8:20:26 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -3.91 | -3.32 | -14.76 | -11.05 |
| Low Estimate | -3.91 | -3.32 | -14.76 | -11.05 |
| High Estimate | -3.91 | -3.32 | -14.76 | -11.05 |
| Year Ago EPS | -455 | -140 | -56.94 | -14.76 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 300k |
| Low Estimate | -- | -- | -- | 300k |
| High Estimate | -- | -- | -- | 300k |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -472.5 | -122.5 | -62.3 | -143.5 |
| EPS Actual | -455 | -140 | -9.54 | 25.2 |
| Difference | 17.5 | -17.5 | 52.76 | 168.7 |
| Surprise % | 3.70% | -14.29% | 84.69% | 117.56% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -3.91 | -3.32 | -14.76 | -11.05 |
| 7 Days Ago | -142.8 | -123.55 | -538.3 | 0 |
| 30 Days Ago | -142.8 | -123.55 | -538.3 | 0 |
| 60 Days Ago | -142.8 | -123.55 | -538.3 | 0 |
| 90 Days Ago | -142.8 | -123.55 | -538.3 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NDRA | 99.14% | 97.63% | 74.08% | 25.14% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Ascendiant Capital: Buy to Buy | 4/21/2025 |
| Maintains | Ascendiant Capital: Buy to Buy | 6/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy | 3/31/2023 |
Related Tickers
BIAF bioAffinity Technologies, Inc.
0.2060
+2.23%
APDN Applied DNA Sciences, Inc.
0.8210
-2.94%
MYGN Myriad Genetics, Inc.
3.8900
-3.47%
ISPC iSpecimen Inc.
1.1379
-1.91%
ADVB Advanced Biomed Inc.
0.9489
-11.32%
BDSX Biodesix, Inc.
0.3716
+6.84%
PRPH ProPhase Labs, Inc.
0.3030
-0.33%
NEOG Neogen Corporation
5.97
-0.33%
TTOO T2 Biosystems, Inc.
0.1311
-5.72%
CHEK Check-Cap Ltd.
0.8193
-7.93%